FOS and melanoma: Table 7 lists the selected differentially expressed immune genes by recurrence status in the yr60+ melanoma patients with p<0.05 and absolute fold change > 0.5. In yr60+ patients with positive SLNs, highly expressed FOS and CCL18 were associated with recuryes. A volcano plot of the immune genes that was differentially expressed in older patients in the recuryes versus the recurno group is shown in Supplementary Figure 5.